Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > AWARE-1 KOL CALL with Dr. Aleix Prat of SOLTI

<< Previous

Bullboard Posts

Next >>

Comment by famaron Jun 04, 2020 9:56pm

435 Views

Post# 31114535

RE:RE:RE:RE:AWARE-1 KOL CALL with Dr. Aleix Prat of SOLTI

Been chipping away myself, still can't get over from the reality that I lost the opportunity of a life time when Valeant bought out Biovail. At that time we were working on a huge contract from Biovail. Don't kid yourself, the're many studies taking place on these cancers.

ONC seems to have something going for them since they're being so open on their developments. I won't worry about any partnership yet. May be we may have a few companies out of ONC. The fun is yet to come, if we begin to trade 3-4-mil-day. Good buying opportunity IMHO.

GLTA....fmb

<< Previous

Bullboard Posts

Next >>

These stocks are the top picks for Canadian ETFs